Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Current Leases (2019 - 2025)

vTv Therapeutics' Current Leases history spans 7 years, with the latest figure at $32000.0 for Q3 2025.

  • For Q3 2025, Current Leases fell 82.32% year-over-year to $32000.0; the TTM value through Sep 2025 reached $32000.0, down 82.32%, while the annual FY2024 figure was $169000.0, 0.0% changed from the prior year.
  • Current Leases for Q3 2025 was $32000.0 at vTv Therapeutics, down from $79000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $208000.0 in Q3 2022 and bottomed at $32000.0 in Q3 2025.
  • The 5-year median for Current Leases is $169000.0 (2021), against an average of $159526.3.
  • The largest annual shift saw Current Leases grew 19.12% in 2021 before it crashed 82.32% in 2025.
  • A 5-year view of Current Leases shows it stood at $184000.0 in 2021, then decreased by 16.3% to $154000.0 in 2022, then increased by 9.74% to $169000.0 in 2023, then changed by 0.0% to $169000.0 in 2024, then crashed by 81.07% to $32000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Current Leases are $32000.0 (Q3 2025), $79000.0 (Q2 2025), and $125000.0 (Q1 2025).